MedTrace Logo

Evaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease

NCT07066865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2025-07-15

No results posted yet for this study

Summary

A case series of patients presented with graft versus host disease with ocular involvement . The study recruited a total of 3 patients who were referred to cornea clinic of Farwaniya Hospital, Kuwait between April 2022 and April 2024. All cases presented with severe dryness, spks and corneal epithelial defect not responding to other measures of treatment. An OmniLenz was applied for each patient for one week. Primary outcome measures included healing of the corneal resistant epithelial defect, secondary outcome measures were improvement of signs of dryness.

Conditions

  • Ocular Graft Versus Host Disease

Interventions

DEVICE

omniLenz

sutureless dehydrated amniotic membrane (omnigen) mounted on contact lens (omnilenz)

Sponsors & Collaborators

  • Farwaniya Hospital

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • Kuwait

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07066865 on ClinicalTrials.gov